Scientists discover how common treatment-related cancer develops
(Medical Xpress) -- Scientists in a team at Newcastle University have identified a mechanism by which treatment-related leukaemia develops, raising hopes that this side effect of toxic chemotherapy could be prevented.
Acute myeloid leukaemia (AML) is a blood cancer that can arise as a consequence of treatment for other cancers. AML is diagnosed in 2,200 adults each year and it is thought that up to 10% of these cases are treatment-related.
Leukaemia is often triggered by DNA mutations within white blood cells when part of one chromosome exchanges with part of another in a process called translocation. For these chromosome rearrangements to occur, their constituent DNA must be broken and then repaired incorrectly. These mutated cells then divide uncontrollably in the blood, crowding out healthy blood cells.
Up to a third of treatment-related cases of AML can be attributed to chromosome rearrangements caused by the interaction between anti-cancer drugs and an enzyme called TOP2B. This enzyme is critical in managing DNA movement within cells and many cancers including lymphoma, testicular, lung and prostate cancers are sensitive to drugs that block its activity.
In work funded by the charity Leukaemia & Lymphoma Research and published online in the journal Proceedings of the National Academy of Sciences, the Newcastle scientists showed that while drugs designed to inhibit TOP2 can be highly effective in preventing the rapid division of cancer cells, in some cases these drugs also cause key regions of important chromosomes to be held close together in a manner that increases the likelihood that the leukaemia inducing translocations occur.
Professor Caroline Austin, who led the team at the Institute for Cell and Molecular Biosciences at Newcastle University, said: We are working to understand more about how these DNA breaks and rearrangements are made. The hope is that we will now be able to find ways of altering drug treatments to block this process, preventing secondary cancers from developing.
Professor Chris Bunce, Research Director at Leukaemia & Lymphoma Research, said: Although thankfully relatively rare, diagnosis with a second cancer due to treatment is a devastating blow for patients. It is vital that we reform and improve standard chemotherapy drugs to not just make them more effective but also reduce side-effects. This study represents a huge breakthrough. It is the first time that scientists have looked into what is going on in the cell nucleus and explained exactly what happens when treatment-related DNA mutations occur.
Journal reference: Proceedings of the National Academy of Sciences
Provided by Newcastle University
- Scientists find new drug target for hard-to-treat leukaemia Mar 30, 2012 | not rated yet | 0
- Cell death researchers identify new Achilles heel in acute myeloid leukemia Jan 17, 2012 | not rated yet | 0
- Scientists find genetic key to why some cancer patients don't respond to treatment Jan 05, 2012 | not rated yet | 0
- Researchers’ blood cancer breakthrough Aug 10, 2011 | not rated yet | 0
- An unexpected way to cause leukemia Apr 07, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
Cancer 10 hours ago | not rated yet | 0
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
Cancer 10 hours ago | not rated yet | 1
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
Cancer May 18, 2013 | 5 / 5 (2) | 0
(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...
Cancer May 17, 2013 | not rated yet | 0
(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...
Cancer May 17, 2013 | not rated yet | 0 |
The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.
1 hour ago | not rated yet | 0
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
2 hours ago | not rated yet | 0
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
10 hours ago | not rated yet | 0 |
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
10 hours ago | 4.7 / 5 (3) | 0 |
There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).
10 hours ago | not rated yet | 0